Design and rationale of the reevaluation of systemic early neuromuscular blockade trial for acute respiratory distress syndrome

Annals of the American Thoracic Society

Volumn 14, Issue 1, 2017, Pages 124-133

  Huang, David T ^a   Angus, Derek C ^a   Moss, Marc ^b   Thompson, B Taylor ^c   Ferguson, Niall D ^d   Ginde, Adit ^b   Gong, Michelle Ng ^e   Gundel, Stephanie ^f   Hayden, Douglas L ^c   Hite, R Duncan ^g   Hou, Peter C ^c   Hough, Catherine L ^f   Iwashyna, Theodore J ^h   Liu, Kathleen D ⁱ   Talmor, Daniel S ^c   Yealy, Donald M ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g LERNER RESEARCH INSTITUTE   (United States)

^h UNIVERSITY OF MICHIGAN   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adult; Clinical trial; Interdisciplinary communication; Methods; Respiratory distress syndrome

Indexed keywords

CISATRACURIUM; ATRACURIUM BESILATE; NEUROMUSCULAR BLOCKING AGENT;

ACUTE DISEASE; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; HEMODYNAMIC MONITORING; HOSPITAL DISCHARGE; HUMAN; MORTALITY; MULTICENTER STUDY; NEUROMUSCULAR BLOCKING; POSITIVE END EXPIRATORY PRESSURE; PROTOCOL COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; TIDAL VOLUME; ANALOGS AND DERIVATIVES; ARTIFICIAL VENTILATION; CAUSE OF DEATH; CLINICAL TRIAL; FEASIBILITY STUDY; MUSCLE STRENGTH; PROCEDURES; RECALL;

ATRACURIUM; CAUSE OF DEATH; FEASIBILITY STUDIES; HUMANS; MENTAL RECALL; MORTALITY; MUSCLE STRENGTH; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR BLOCKING AGENTS; POSITIVE-PRESSURE RESPIRATION; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 85008368392     PISSN: 23256621     EISSN: None     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201608-629OT     Document Type: Article

References (45)

1. Ferguson ND, Fan E, Camporota L, Antonelli M, Anzueto A, Beale R, Brochard L, Brower R, Esteban A, Gattinoni L, et al. The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material. Intensive Care Med 2012;38: 1573-1582.
2. Papazian L, Forel JM, Gacouin A, Penot-Ragon C, Perrin G, Loundou A, Jaber S, Arnal JM, Perez D, Seghboyan JM, et al.; ACURASYS Study Investigators. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 2010;363:1107-1116.
3. Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, Gattinoni L, van Haren F, Larsson A, McAuley DF, et al.; LUNG SAFE Investigators; ESICM Trials Group. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 2016;315:788-800.
4. Slutsky AS. Neuromuscular blocking agents in ARDS. N Engl J Med 2010;363:1176-1180.
5. Hughes CG, McGrane S, Pandharipande PP. Sedation in the intensive care setting. Clin Pharmacol 2012;4:53-63.
6. Reade MC, Finfer S. Sedation and delirium in the intensive care unit. N Engl J Med 2014;370:444-454.
7. Baron R, Binder A, Biniek R, Braune S, Buerkle H, Dall P, Demirakca S, Eckardt R, Eggers V, Eichler I, et al.; DAS-Taskforce 2015. Evidence and consensus based guideline for the management of delirium, analgesia, and sedation in intensive care medicine: revision 2015 (DAS-Guideline 2015)-short version. Ger Med Sci 2015;13:Doc19.
8. Barr J, Fraser GL, Puntillo K, Ely EW, Gélinas C, Dasta JF, Davidson JE, Devlin JW, Kress JP, Joffe AM, et al.; American College of Critical Care Medicine. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med 2013;41:263-306.
9. Marini JJ. Early phase of lung-protective ventilation: a place for paralytics? Crit Care Med 2006;34:2851-2853.
10. Schulz KF, Altman DG, Moher D; CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoS Med 2010;7:e1000251.
11. Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P; CONSORT Group. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med 2008;148:295-309.
12. Truwit JD, Bernard GR, Steingrub J, Matthay MA, Liu KD, Albertson TE, Brower RG, Shanholtz C, Rock P, Douglas IS, et al.; National Heart Lung and Blood Institute ARDS Clinical Trials Network. Rosuvastatin for sepsis-associated acute respiratory distress syndrome. N Engl J Med 2014;370:2191-2200.
13. Meade MO, Cook DJ, Guyatt GH, Slutsky AS, Arabi YM, Cooper DJ, Davies AR, Hand LE, Zhou Q, Thabane L, et al.; Lung Open Ventilation Study Investigators. Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA 2008;299:637-645.
14. Ferguson ND, Cook DJ, Guyatt GH, Mehta S, Hand L, Austin P, Zhou Q, Matte A, Walter SD, Lamontagne F, et al.; OSCILLATE Trial Investigators; Canadian Critical Care Trials Group. High-frequency oscillation in early acute respiratory distress syndrome. N Engl J Med 2013;368:795-805.
15. Guérin C, Reignier J, Richard JC, Beuret P, Gacouin A, Boulain T, Mercier E, Badet M, Mercat A, Baudin O, et al.; PROSEVA Study Group. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med 2013;368:2159-2168.
16. DellaVolpe JD, Chakraborti C, Cerreta K, Romero CJ, Firestein CE, Myers L, Nielsen ND. Effects of implementing a protocol for arterial blood gas use on ordering practices and diagnostic yield. Healthc (Amst) 2014;2:130-135.
17. McCanny P, Bennett K, Staunton P, McMahon G. Venous vs arterial blood gases in the assessment of patients presenting with an exacerbation of chronic obstructive pulmonary disease. Am J Emerg Med 2012;30:896-900.
18. Ma OJ, Rush MD, Godfrey MM, Gaddis G. Arterial blood gas results rarely influence emergency physician management of patients with suspected diabetic ketoacidosis. Acad Emerg Med 2003;10: 836-841.
19. Kelly AM, McAlpine R, Kyle E. Venous pH can safely replace arterial pH in the initial evaluation of patients in the emergency department. Emerg Med J 2001;18:340-342.
20. Pilon CS, Leathley M, London R, McLean S, Phang PT, Priestley R, Rosenberg FM, Singer J, Anis AH, Dodek PM. Practice guideline for arterial blood gas measurement in the intensive care unit decreases numbers and increases appropriateness of tests. Crit Care Med 1997;25:1308-1313.
21. Brown SM, Grissom CK, Moss M, et al. Non-linear imputation of PaO/ FIO from SpO/FIO among patients with Acute Respiratory Distress Syndrome. Chest 2016;150:307-313.
22. Rice TW, Wheeler AP, Bernard GR, Hayden DL, Schoenfeld DA, Ware LB; National Institutes of Health National Heart Lung and Blood Institute ARDS Network. Comparison of the SpO2/FIO2 ratio and the PaO2/FIO2 ratio in patients with acute lung injury or ARDS. Chest 2007;132:410-417.
23. Ellis RK. Determination of PO2 from saturation. J Appl Physiol (1985) 1989;67:902.
24. Strange C, Vaughan L, Franklin C, Johnson J. Comparison of train-offour and best clinical assessment during continuous paralysis. Am J Respir Crit Care Med 1997;156:1556-1561.
25. Rudis MI, Sikora CA, Angus E, Peterson E, Popovich J Jr, Hyzy R, Zarowitz BJ. A prospective, randomized, controlled evaluation of peripheral nerve stimulation versus standard clinical dosing of neuromuscular blocking agents in critically ill patients. Crit Care Med 1997;25:575-583.
26. Baumann MH, McAlpin BW, Brown K, Patel P, Ahmad I, Stewart R, Petrini M. A prospective randomized comparison of train-of-four monitoring and clinical assessment during continuous ICU cisatracurium paralysis. Chest 2004;126:1267-1273.
27. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000;342:1301-1308.
28. Brower RG, Lanken PN, MacIntyre N, Matthay MA, Morris A, Ancukiewicz M, Schoenfeld D, Thompson BT; National Heart Lung and Blood Institute ARDS Clinical Trials Network. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 2004;351:327-336.
29. Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, deBoisblanc B, Connors AF Jr, Hite RD, Harabin AL; National Heart Lung and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Comparison of two fluidmanagement strategies in acute lung injury. N Engl J Med 2006;354: 2564-2575.
30. Mercat A, Richard JC, Vielle B, Jaber S, Osman D, Diehl JL, Lefrant JY, Prat G, Richecoeur J, Nieszkowska A, et al.; Expiratory Pressure (Express) Study Group. Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA 2008;299:646-655.
31. Grissom CK, Hirshberg EL, Dickerson JB, Brown SM, Lanspa MJ, Liu KD, Schoenfeld D, Tidswell M, Hite RD, Rock P, et al.; National Heart Lung and Blood Institute Acute Respiratory Distress Syndrome Clinical Trials Network. Fluid management with a simplified conservative protocol for the acute respiratory distress syndrome. Crit Care Med 2015;43:288-295.
32. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, et al.; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013;41:580-637.
33. Schoenfeld DA, Hayden D, Oldmixon C, Ringwood N, Thompson BT. Statistical design and analysis issues for the ARDS Clinical Trials Network: the Coordinating Center perspective. Future Science 2012: 275-289.
34. Kahn JM, Benson NM, Appleby D, Carson SS, Iwashyna TJ. Long-term acute care hospital utilization after critical illness. JAMA 2010;303: 2253-2259.
35. Taori G, Ho KM, George C, Bellomo R, Webb SA, Hart GK, Bailey MJ. Landmark survival as an end-point for trials in critically ill patients- comparison of alternative durations of follow-up: an exploratory analysis. Crit Care 2009;13:R128.
36. Tipping CJ, Bailey MJ, Bellomo R, Berney S, Buhr H, Denehy L, Harrold M, Holland A, Higgins AM, Iwashyna TJ, et al. The ICU Mobility Scale has construct and predictive validity and is responsive: a multicenter observational study. Ann Am Thorac Soc 2016;13:887-893.
37. Avidan MS, Palanca BJ, Glick D, Jacobsohn E, Villafranca A, O'Connor M, Mashour GA; BAG-RECALL Study Group. Protocol for the BAGRECALL clinical trial: a prospective, multi-center, randomized, controlled trial to determine whether a bispectral index-guided protocol is superior to an anesthesia gas-guided protocol in reducing intraoperative awareness with explicit recall in high risk surgical patients. BMC Anesthesiol 2009;9:8.
38. Avidan MS, Jacobsohn E, Glick D, Burnside BA, Zhang L, Villafranca A, Karl L, Kamal S, Torres B, O'Connor M, et al.; BAG-RECALL Research Group. Prevention of intraoperative awareness in a highrisk surgical population. N Engl J Med 2011;365:591-600.
39. Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS; ARDS Definition Task Force. Acute respiratory distress syndrome: the Berlin definition. JAMA 2012;307: 2526-2533.
40. Rice TW, Wheeler AP, Thompson BT, Steingrub J, Hite RD, Moss M, Morris A, Dong N, Rock P; National Heart Lung and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Initial trophic vs full enteral feeding in patients with acute lung injury: the EDEN randomized trial. JAMA 2012;307:795-803.
41. Lan KKG, DeMets DL. Discrete sequential boundaries for clinical trials. Biometrika 1983;70:659-663.
42. Montori VM, Devereaux PJ, Adhikari NK, Burns KE, Eggert CH, Briel M, Lacchetti C, Leung TW, Darling E, Bryant DM, et al. Randomized trials stopped early for benefit: a systematic review. JAMA 2005;294: 2203-2209.
43. Kalbfleisch J, Prentice R. The statistical analysis of failure time data. New York: John Wiley & Sons; 2002
44. Hayden D, Pauler DK, Schoenfeld D. An estimator for treatment comparisons among survivors in randomized trials. Biometrics 2005; 61:305-310.
45. Briel M, Meade M, Mercat A, Brower RG, Talmor D, Walter SD, Slutsky AS, Pullenayegum E, Zhou Q, Cook D, et al. Higher vs lower positive endexpiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis. JAMA 2010;303:865-873.